// App-Quantinova.ai

376 : Improvement of Disease Activity in Patients with Colchicine-Resistant FMF, Hids/Mkd and TRAPS Assessed By Autoinflammatory Disease Activity Index (AIDAI): Results from a Randomized Phase III Trial

Researchers

Presenter

  • Isabelle Kon-Paut

Principal Investigators

  • Michal Hofer

  • Susanne Benseler

  • Jasmin B. Kuemmerle-Deschner

  • Annette Jansson

  • Itzhak Rosner

  • Raffaele Manna

  • Sara Murias

  • Omer Karadag

  • Lori Tucker

  • Ilonka Orban

  • Vincent Tormey

  • Maria Alessio

  • Huri Ozdogan

  • Fabrizio De Benedetti

Medical Centers

  • Bicêtre Hospital, APHP, Univeristy Paris Sud, Paris, France

  • Unité romande d’immuno-rhumatologie pédiatrique, CHUV, University of Lausanne, Genova, Italy

  • Alberta Childrens Hospital, Calgary, AB, Canada

  • University of Tubingen, Tubingen, Germany

  • Ludwig Maximilians University Munich, Munich, Germany

  • Banai-Zion Medical Center, Haifa, Israel

  • Department of Internal Medicine, Università Cattolica Sacro Cuore, Rome, Italy

  • Hospital La Paz, Madrid, Spain

  • Gazi University Faculty of Medicine, Ankara, Turkey

  • BC Children's Hospital, Vancouver, BC, Canada

  • Orszagos Reumatologial es Fizioterepias, Budapest, Hungary

  • ICORG and University College Hospital Galway, Galway, Ireland

  • A Osped-Universit Policlinico Federico II, Univ degli Studi di Napoli, Napoli, Italy

  • Division of Rheumatology, Istanbul University, Cerrahpasa Medical Faculty, Rheumatology, Istanbul, Turkey

  • Istituto Giannina Gaslini - Pediatria II, Reumatologia - PRINTO, GENOA, Italy

Locations

  • France

  • Italy

  • Canada

  • Germany

  • Israel

  • Spain

  • Turkey

  • Hungary

  • Ireland

Companies

  • N/A

Study Components

Therapeutic Area

  • Genetic Disorder

Disease

  • N/A

Biomarkers

  • C reactive protein

  • Serum amyloid A

Drug/Treatment

  • Colchicine

Outcome

  • N/A

Study Design

  • Randomized

Phase

  • III

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved